SlideShare a Scribd company logo
1 of 72
RAHUL ARORA
JR 3 ,
MEDICINE
 WHAT IS EXTRAPYRMIDAL SYSTEM?
 DEFINITION
 ANATOMY
 FUNCTIONS
 APPROACH TO A CASE OF EXTRAPYRMIDAL
DISORDER
• CLASSIFICATION OF EXTRAPYRMIDAL DISORDER
• DEFINATION
• ETIOLOGY
• PATHOPHYSIOLOGY
• DISTINGUISHING FEATURES
 BRIEF DISCUSSION ON
• PARKINSONISM
• HUNTINGTON’ DISEASE
 The term extrapyramidal system, coined by British
neurologist Kinnier Wilson, refers to the basal ganglia
and an array of brain stem nuclei (red nucleus,
reticular formation etc.) to which they are connected.
 Components of the extrapyramidal system include the
red nuclei, vestibular nuclei, superior colliculus and
reticular formation in the brain stem, all of which
project via discrete pathways to influence spinal cord
motor neurons. Cerebellar projections are also
included since they influence not only these brainstem
motor pathways, but also the motor cortex itself via the
dentatothalamic projection.
Basal ganglia
Subcortical nuclei
Caudate,
putamen &
globus pallidus
: corpus
straitum
Caudate &
putamen :
straitum
Globus pallidus &
putamen :
lentiform nuclei
Globus pallidus :
pallidum
Perhaps the most important structures to retain an
extrapyramidal definition are the basal ganglia,
Sub cortical cell stations for the extra pyramidal
motor pathway
The neostriatum (caudate and putamen) receives
widespread cortical afferents, including those from
high order sensory association and motor areas,
and projects mainly to the globus pallidus. The
latter nucleus is the major outflow for the basal
ganglia and, via the ventral anterior thalamus,
exerts its major influence on premotor and hence
the motor cortices.
This pattern of connections suggests that the basal
ganglia are involved in complex aspects of motor
control, including motor planning and the initiation
of movement.
pyramidal system extrapyramidal system
function Skilful volitional
movements
Modulate volitional motor
movements
Finalizes an act Initiate an act
connection Direct linkage to
spinal cord
Multi neuronal and multi
synaptic via descending tracts
Cortico bulbar and
cortical spinal tract
reticulo-spinal, rubro-spinal,
olivo-spinal and vestibulo-spinal
tract.
Clinical features spasticity Rigidity( lead pipe/ cog wheel)
Reflexes brisk normal
Power diminished Usually not affected
Planters extensor flexor
Involuntary movements absent present
 Phylogenetically, corpus striatum is primarily
responsible for stereotyped motor activities to
maintain tone, posture, locomotion and automatic
associated movement.
 Regulation of voluntary motor activity
 Control of the muscle tone
 Maintenance of emotional and associative
movements
It is now clear that in many extrapyramidal disorders there are
specific changes in neurotransmitter profile rather than
discrete anatomical lesions
1. Disturbance in the control of voluntary motor activity resulting
in involuntary movements which may be of two main types:
 Rhythmic and regular as in parkinsonism
 Dysrhythmic and irregular as in chorea, athetosis and dystonia
2. Disturbance in the normal muscle tone resulting in hypertonia
(rigidity)
3. Disturbance in the maintenance of emotional and associated
movements resulting in bradykinesia (mask face, infrequent
blinking and loss of swinging during walking)
Extrapyramidal disorders are classified
broadly on clinical grounds into:
1. The akinetic-rigid syndromes in which
poverty of movements predominates
2. The dyskinesisas in which there are a
variety of excessive involuntary
movements
Akinetic-rigid syndromes
Idiopathic Parkinson's disease
Drug-induced parkinsonism (e.g. phenothiazines)
MPTP-induced parkinsonism [methylphenyltetrahydropyridine]
Postencephalitic parkinsonism
Parkinsonism-plus
Childhood akinetic-rigid syndrome
Dyskinesias
Essential tremor
Chorea
Hemiballismus
Myoclonus
Tic or 'habit spasms'
Torsion dystonias
Paroxysmal dyskinesias
Rhythmical
Tremor
Irregular
Slow or sustained
(Athetosis / dystonia)
Rapid
Controllable
(Tics)
Uncontrollable
Distal
(Chorea)
Proximal
(Ballismus)
Multifocal
(Myoclonus)
Only Cogwheel
rigidity or rest
tremor
(Parkinsonism)
Cognitive, language,
upper motor neuron
or sensory sign
(Degenerative
disease with
parkinsonism)
 Age- age of disease onset is very important tourette
syndrome, typically begins in the first decade,
parkinsons disease usually occurs in late age
 Past history –About infection (rheumatic fever),
jaundice(wilsons disease)
• Medical history & Toxin exposure
 Drug history- of current, previous & recreational use
should be taken details : parkinsonism & dystonia
may be produced by dopamine receptor blocking
agent
 Family history – should be taken and make a
pedigree chart if necessary (huntington disease)
Associated neuropsychiatric features –
Wilson disease, Huntington disease
Autonomic symptoms- dizziness,
bladder complaints, impotence etc may be
prominent & early in MSA,
neurodegenerative disease
Alcohol responsiveness, essential
tremor is characteristically response to
alcohol
 Specific distribution-
• Chorea/ athetosis - mainly in the distal groups
• Hemiballismus- mainly proximally
• Parkinsons disease- mainly unilateral & asymmetric
• Blepherospasm- affect both eye
 Specific action & relationship to voluntary
movement-
• task specific tremor (intention tremor) during pick up a
glass of water
• Task specific dystonia eg: Writers cramp, musician
cramp
 Speed of movement-
 Rhythm-
Continuous – tremor
Intermittent – astrexis
 Relationship to sleep- Palatal myoclonus,
segmental myoclonus, fasciculation &
myokymia, persist during sleep , Dystonia
diminished on sleep
 Supresibility- tics may be voluntary suppressed
Slow Intermediate Fast
Parkinsonism Chorea Myoclonus
Dystonia Tremor Tics
Athetosis
 Aggravating or precipitating factor- stress and
anxiety worsen all movement disorder
• Myoclonus may be triggered by specific stimuli-
sudden loud noise or touch
• Carbohydrate heavy meal, fatigue may precipitate
paroxysmal dystonia
 Associated sensory symptom- RLS
associated with pain or discomfort, tics may be
associated with vague discomfort or abnormal
sensation
 Ameliorating factor- alcohol dramatically
improved essential tremor and myoclonic
dystonia
 2nd commonest neurodegenerative
disease of neurons in the nigrostrial
dopamine system
Clinical Features of Parkinson's Disease
Cardinal Features Other Motor Features Nonmotor Features
Bradykinesia
Rest tremor
Rigidity
Gait disturbance/postural
instability
Micrographia
Masked facies
(hypomimia)equalize
Reduced eye blink
Soft voice (hypophonia)
Dysphagia
Freezing
Anosmia
Sensory disturbances
(e.g., pain)
Mood disorders (e.g.,
depression)
Sleep disturbances
Autonomic disturbances
Orthostatic hypotension
Gastrointestinal
disturbances
Genitourinal disturbances
Sexual dysfunction
Cognitive
impairment/Dementia
1- Static tremors
 Rhythmic occuring at a rate of 4-8 / second
 May start in one hand and spread to other
parts of the body
 Characteristically pill-rolling movements
between the thumb and the forefinger are
seen
 Tremors increase with emotional, anxiety and
fatigue and disappear during sleep and during
active voluntary movements
2- Rigidity of the muscles
 More proximal than distal
 Flexors are affected more than extensor
 On clinical examination the resistance may be
continuous throughout the act to the same
degree (lead pipe rigidity) or interrupted by
the tremors (cog wheel rigidity)
 Stiffness of the limbs develops causing
difficulty in starting movements and walking
(slow, shuffling gait)
3- Akinesia: Loss of emotional and
associative movements resulting in:
Immobile face with infrequent blinking
(mask face)
Monotonous speech
Loss of swinging of the arms during
walking
 Pathologically, the hallmark features of PD are degeneration of dopaminergic
neurons in the substantia nigra pars compacta (SNc), reduced striatal dopamine,
and intracytoplasmic proteinaceous inclusions known as Lewy bodies.
 neuronal degeneration with inclusion body formation can also affect cholinergic
neurons of the nucleus basalis of Meynert (NBM), norepinephrine neurons of the
locus coeruleus (LC), serotonin neurons in the raphe nuclei of the brainstem, and
neurons of the olfactory system, cerebral hemispheres, spinal cord, and
peripheral autonomic nervous system.
 Indeed, there is evidence that pathology begins in the peripheral autonomic
nervous system, olfactory system, and dorsal motor nucleus of the vagus nerve in
the lower brainstem, and then spreads in a sequential manner to affect the upper
brainstem and cerebral hemispheres. These studies suggest that dopamine
neurons are affected in midstage disease.
 Several studies suggest that symptoms reflecting nondopaminergic degeneration
such as constipation, anosmia, rapid eye movement (REM) behavior sleep
disorder, and cardiac denervation precede the onset of the classic motor features
of the illness.
Differential Diagnosis of Parkinsonism
Parkinson's Disease
Genetic
Sporadic
Dementia with Lewy
bodies
Atypical
Parkinsonisms
Multiple-system
atrophy
Cerebellar type
(MSA-c)
Parkinson type
(MSA-p)
Progressive
supranuclear palsy
Corticobasal
ganglionic
degeneration
Frontotemporal
dementia
Secondary
Parkinsonism
Drug-induced
Tumor
Infection
Vascular
Normal-pressure
hydrocephalus
Trauma
Liver failure
Toxins (e.g.,
carbon monoxide,
manganese,
MPTP, cyanide,
hexane, methanol,
carbon disulfide)
Other Neurodegenerative
Disorders
Wilson's disease
Huntington's disease
Neurodegeneration with
brain iron accumulation
SCA 3 (spinocerebellar
ataxia)
Fragile X–associated
ataxia-tremor-
parkinsonism
Prion disease
Dystonia-parkinsonism
(DYT3)
Alzheimer's disease with
parkinsonism
Modern immunocytochemical techniques and genetic findings
suggest that Parkinson-plus syndromes can be broadly grouped
into 2 types: synucleinopathies and tauopathies. Clinically,
however, 5 separate Parkinson-plus syndromes have been
identified, as follows:
1. Multiple system atrophy
2. Progressive supranuclear palsy
3. Parkinsonism-dementia-amyotrophic lateral sclerosis complex
4. Corticobasal ganglionic degeneration
5. Diffuse Lewy body disease
Parkinson-plus syndromes respond poorly to the standard
treatments for Parkinson disease (PD).
In addition to lack of response to levodopa/carbidopa
(Sinemet) or dopamine agonists in the early stages of
the disease, other clinical clues suggestive of
Parkinson-plus syndromes include the following:
History and Examination Features Suggesting Diagnoses Other Than Parkinson's
Disease
Symptoms/Signs Alternative Diagnosis to Consider
History
Falls as the first symptom PSP
Exposure to neuroleptics Drug-induced parkinsonism
Onset prior to age 40 If PD, think genetic causes
Associated unexplained liver disease Wilson's disease
Early hallucinations Lewy body dementia
Sudden onset of parkinsonian symptoms Vascular parkinsonism
Physical Exam
Dementia as first symptom Dementia with Lewy bodies
Prominent orthostasis MSA-p
Early dysarthria MSA-c
Lack of tremor Various Parkinson's-plus syndromes
High frequency (8–10 Hz) symmetric tremor Essential tremor
Diagnosis of PD
 clinical examination
 No disease-specific biological marker
available
 Positron Emission Tomography (PET)
or Single-photon Emission Computed
Tomography (SPECT) with
dopaminergic radioligands
 Exclusion of several causes of
secondary Parkinsonism
(A)  Dopamine
 Carbidopa/l-dopa
 Dopamine agonists: Apomorphine(off phenomenon),
 s/c, i.v.
Cabergoline
Ropinirole,
Pramipexole
 COMT inhibitors: Entacapone
 MAO Inhibitors: e.g. Selegiline (B-type)
 Inhibitors of dopamine re-uptake: Amantadine
(2)  Acetylcholine
 Anticholinergic
 Antihistaminics
Drugs commonly used in the treatment of Parkinson disease
MEDICATION
STARTING
DOSE
TARGET
DOSE MAIN BENEFIT SIDE EFFECTS
Carbidopa-L-dopa
(Sinemet)
25/100 tid
empty
stomach
Up to 50/250
q 3 h
Reduction of tremor and
bradykinesia; less effect on
postural difficulties
Nausea, dyskinesias, orthostatic
hypotension, hallucinations,
confusion, arrhythmia
Controlled release
carbidopa-L-dopa
25/100 tid Up to 50/200
q 4 h
Dopamine agonists
Ropinirole(D3) 0.125 mg
tid
0.5 to 1.5
mg/day
Moderate effects on all
aspects; reduced motor
fluctuations of L-dopa,
neuroprotective, neurotrophic
Orthostatic hypotension,
excessive and abrupt
sleepiness, confusion,
hallucinations, impulse control
disorders
Pramipexole(D2) 0.25 mg tid 8 to 24
mg/day
Glutamate agonist
Amantadine
(Symmetrel)
100
mg/day
100 mg bid-tidSmoothing of motor
fluctuations
Leg swelling, congestive heart
failure, prostatic outlet
obstruction, confusion,
hallucinations, insomnia
Anticholinergics
Benztropine
(Cogentin)
0.5 mg per
day
Up to 4 mg
per day
Tremor reduction, less effect
on other features, drug
induced parkinsonism
Atropinic effects: dry mouth,
urinary outlet obstruction,
confusion and psychosisTrihexyphenidyl
(Artane)
0.5 mg bid Up to 2 mg tid
MAO-B inhibitor
selegiline, 5mg/day bd Neuroprotection, adjuntive
therapy
Insomnia
Rasagiline 1mg/day
COMT inhibitors
Entacapone 200 mg with L-dopa Urine discoloration, diarrhea,
increased dyskinesias
 Stereotactic neurosurgery: pallidotomy, thalamotomy ,sub
thalamotomy
Indications
1.idiopathic parkinsons
2.levodopa unhelpful
3.intractable PD
4.drug dyskinesias
 Deep brain stimulation: dyskinesia
 Tissue transplantation: Experimental transplantation of fetal
or autologous dopamine-containing adrenal medulla or stem
cell research has produced no promising results in PD to date.
 Physiotherapy and physical aids
 Neuropsychiatric aspects: Cognitive impairment and
depression are common as PD progresses. SSRIs are the
drugs of choice for depression.
 Sudden, brief, rapid, jerky, purposeless, non-
repetitive, involuntary movement
 Most characteristically in distal parts of upper
extremity but may also involved proximal part,
lower extremity, trunk, face & tongue
PATHOLOGY
 Damage to caudate nucleus
 Disease characterized by chorea:
 Inherited disorder: Huntington disease, wilson
disease, benign hereditry chorea,
neuroacanthocytosis
 Infectious causes: Rheumatic chorea
(sydenham chorea), HIV disease
 Structural lesion of the basal ganglia- infarct,
neoplasm, trauma
 Chorea of systemic disease: SLE,
thyrotoxicosis, polycythemia vera,
hyperosmolar non-ketotic hyperglycemia
 Pregnancy (chorea gravidarum)
 Drugs: Neuroleptics, OCP, excessive dose of
levodopa or dopamine agonist, phenytoin
cocaine
 Hypotonia
 Pronator sign
 Milkmaid’s grip
 Spooning sign
 Pendular knee jerk “hung up reflex”
 Lizard tongue
Increased by excitement, diminished by sleep
Sydenham chorea (Saint vitus dance) more common in
female and childhood (5-15yrs), associated with prior
exposer to group a streptococcal infection, late
manifestation
Huntington's disease progressive fatal autosomal
dominant disorder characterized by motor, behavioral
& cognitive dysfunction, in early stages chorea is focal
or segmental but it progress over time to involve
multiple body region
Etiology
 HD is caused by an increase in the
number of polyglutamine (CAG)
repeats (>40) in the coding sequence
of the huntingtin gene located on the
short arm of chromosome 4. The larger
the number of repeats, the earlier the
disease is manifest.
Treatment
 multidisciplinary approach
 Dopamine-blocking agents may control
the chorea. Tetrabenazine
 depression and anxiety can be greater
problems, and patients should be
treated with appropriate antidepressant
and antianxiety drugs and monitored for
mania and suicidal ideations.
 Psychosis can be treated with atypical
neuroleptics such as clozapine,
quetiapine, and risperidone
 There is no adequate treatment for the
cognitive or motor decline
 Slow, distal, purposeless, writhing involuntary
movement
 They are more sustained and larger in amplitude
than those in chorea
 The mainly involved the extremities (distal
portion, fingers & hands) face, neck & trunk
 Movement are characterized by any combination
flexion, extension, abduction, pronation, &
supination often alternating and in varying
degree
 Predominant pathologic changes are in the
putamen
Causes: cerebral palsy, perinatal injury to
basal ganglia, wilson disease
Choreoathetosis: the movement live
between chorea & athetosis in rate and
rhythmicity eg: cerebral palsy ( Neonatal
jaundice)
Pseudoathetosis: (sensory athetosis)
undulating & writhing movement of
extremities due to loss of position sense as
a result of parietal lobe lesion, tabes
dorsalis, peripheral nerve disease
A wild, flinging, large amplitude
movements on one side of the body
Proximal upper limb muscles
predominantly affected
Ballastic movement of hemiballismus
resemble that of chorea but are more
pronounced, rapid & forceful
Movement ceaseless during the walking
state and disappear only with the deep
sleep
 Usually self limiting and tends to resolve
spontaneously after weeks to months
 Due to infarction or hemorrhage in the
regions of contralateral subthalamic nucleus,
results in disinhibition of the motor thalamus
and cortex resulting in contralateral
hyperkinetic movement.
 Treatment:
 Dopa blocking agent
 Pallidotomy can be done.
 Sustained or repetitive involuntary muscle contraction leading to twisting
movements and abnormal posture
 Can involve individual muscle or multiple muscle groups.
 Often affect the extremities neck, trunk, eyelids, face & vocal cords
 Dystonic movements are patterned tending to recur in same location
 When duration is very brief less than one second- dystonic spasm, when
for several seconds, dystonic movement & when prolonged minutes to
hours- dystonic posture
Pathophysiology of Dystonia
 not known.
 co-contracting synchronous bursts of agonist and antagonist muscle groups
due to loss of inhibition at multiple levels of the nervous system as well as
increased cortical excitability and reorganization.
 Attention has focused on the basal ganglia as the site of origin of at least
some types of dystonia as there are alterations in blood flow and metabolism
in basal ganglia structures. Further, ablation or stimulation of the globus
pallidus can both induce and ameliorate dystonia.
 Dystonia can be generalized or focal: primary or
secondary
 Generalized dystonia is mainly primary
dystonia involving larger portion of body often
producing distorted posture of limbs & trunk
(Torsion dystonia)
 Idiopathic torsion dystonia (dystonia musculorm
deformance) is predominantly childhood onset
form of dystonia with autosomal dominant
pattern of inheritance
 May starts distally usually in the foot in the
planter flexation & inversion & speed to opposite
side, upper extremity trunk & face
 There is peculiar axial involvement of spine
(twisting)
 Dopa responsive dystonia ( Segawa variant)
dominantly inherited form of dystonia in early
childhood 1-12yrs typically present with foot
dystonia resulting in gait disturbance and there is
excellent response to small doses of levodopa.
 Diurnal variation, worsen with day progresses
Focal dystonia is a most common, 4th to 6th
decade and more common in female:
• Blephero spasm
• Oromandibular dystonia
• Spasmodic dysphonia
• Cervical dystonia
• Limb dystonia (writer’s cramp)
Secondary dystonia:
Due to drugs: Neuroleptics,
(Phenothiazine, Butyrophenone), chronic
levodopa treatment in parkinsons disease
 Discrete lesion in the stratum, palladum,
thalamus, cortex & brain stem
Dystonia plus syndrome:
May occur in the neurodegenerative
condition (Huntington disease, Wilson
disease, parkinson disease, corticobasal
degeneration & progressive supranuclear
palsy)
symptomatic
 Levodopa should be tried in all cases of childhood-onset dystonia to
rule out DRD.
 High-dose anticholinergics (e.g., trihexyphenidyl 20–120 mg/d) may
be beneficial in children, but adults can rarely tolerate high doses
because of cognitive impairment with hallucinations.
 Oral baclofen (20–120 mg), Tetrabenazine (the usual starting dose is
12.5 mg/d and the average treating dose is 25–75 mg/d) may be
helpful in some patients, but use may be limited by sedation and the
development of parkinsonism.
 Botulinum toxin has become the preferred treatment for patients with
focal dystonia, particularly where involvement is limited to small
muscle groups such as in blepharospasm, torticollis, and spasmodic
dysphonia.
 Surgical therapy is an alternative for patients with severe dystonia
who are not responsive to other treatments. Peripheral procedures
such as rhizotomy and myotomy were used in the past to treat
cervical dystonia, but are now rarely employed. DBS of the pallidum
can provide dramatic benefits for patients with primary DYT1
dystonia
 Supportive treatments such as physical therapy and education are
important and should be a part of the treatment regimen.
 Sudden, brief (<100ms) shock like, jerky
involuntary movement consisting of single or
repetitive muscle discharges
 Myoclonus is seen principally in the muscles of
extremities and trunk but the involvement is often
multifocal, diffuse or wide spread
 Can often spontaneously, association with
voluntary movement (action myoclonus) or in
response to external stimulus (reflex or startle
myoclonus)
 Myoclonic jerks defer from tics in that they
interfere with normal movement and not
suppressible
Symptomatic causes of myoclonus:
 Metabolic endogenous- Hypoxia, uraemia,
hepatic failure, hypoglycemia, hyponatraemia,
non-ketotic hyperglycemia
 Degenerative: Alzheimer’s disease, Huntington
disease, multisystem atrophy, corticobasal
degeneration
 Infectious: Creutzfeldt –Jakob disease, EBV etc
 Autoimmune: Multiple sclerosis
 Neoplastic: Neuroblastoma, paraneoplastic
disorders (ovarian, lung & breast)
 Frequently associated with epilepsy, electric
shock, heat stroke
 Drugs: Amantadine, lithium, metoclopramide,
levodopa & dopamine agonist, cocaine,
strychnine
 Opsoclonus- Myoclonus (Kinsbourne
syndrome)- Dancing eye & dancing feet
 Due to the post infectious encephalopathy or as a
paraneoplastic syndrome due to neuroblastoma
 Palatal myoclonus- involuntary rhythmic movement
of soft palate and pharynx the movements are
generally not influenced by drugs or sleep palatal
myoclonus occur with lesions involving the
connections between the inferior olivary, dentate &
red nuclei
 Astrexis: particularly in hepatic encephalopathy,
negative myoclonus inability to sustained normal
muscle tone presenting with slow & irregular
flapping motion
 Acute- Dystonia is most common acute drug
reaction can develop within minutes of exposure
typically generalized in children and focal in adults
 Treatment: parenteral administration of
anticholinergics (benztropine or diphenhydramine)
or benzodiazepines (lorazepam or diazepam).
 Subacute- Akathisia is commonest reaction it
consist of motor restlessness within in need to move
and that to elevated by movement.
 Treatment: Removing the offending agent.If not
possible, give benzodiazepines, anticholinergics,
blockers, or dopamine agonists for symptomatic
improvement.
Chronic- Tardive syndrome after months to years after initiation
of treatment
A typically comprises choreiform movement involving the mouth
lip, tongue, and in severe cases trunk, limbs and respiratory
muscles can be affected
Is more common in elderly women & with underlying organic
cerebral dysfunction (Schrizophrenia)
 Brief, repeated, sterotyped muscle contraction
that often suppressible
 Quick, irregular, seemingly purposeful act but
relatively involuntary
 Patient have some degree of awareness of
movement and in response to urge of some
compelling inner forces
 Exaggerated by emotional strain and tension and
stop during sleep
 May involved any portion of body
 Eg: Repetitive blinking, facial contortions,
shoulder shrugging, also involved vocal tract
producing throat clearing
 Gilles de la Tourette Syndrome characterized
by multiple motor tics and vocalizations
 Motor tics can be simple/ complex & vocal
tics can be simple (grunting) or complex
(echolalia)
 Tourette syndrome is a disease of early
childhood in the first decade and mainly in
Boys an associated with some regressive
behaviour
 Contrary to dopamine, it can pass into the brain
where it is decarboxylated into dopamine
 Levodopa is combined with a peripheral L-AA
decarboxylase inhibitor e.g. carbidopa or
benserazid to
  delivery of l-dopa into the brain
  peripheral adverse effects of dopamine
  Carbidopa if peripheral adverse effects are
prominent
 It has dramatic initial response, decreases with
time (wear off) due to the progressive loss of
neurons
Combined with carbidopa is the most
potent oral therapy for Parkinson’s disease
Symptoms of Parkinson’s disease but
does not stop the progression
(deterioration) of the disease i.e.
Symptomatic treatment
From the third year its efficacy declines
 Peripheral:
• GIT: Nausea & Vomiting
• CVS: Orthostatic hypotension, Dysrhythmias
• Blood dyscrasias & Positive reaction to Coombs
test
• Mydriasis and Brownish discoloration of urine &
saliva
 CNS Effects:
• Visual & Auditory hallucinations & vivid dreams
• Dyskinesias: opposite of Parkinsonian symptoms
• Mood changes, depression & Anxiety
 Long-term levodopa Complications:
• Wearing off (fluctuations), Dyskinesias
Ergot alkaloid derivatives:
Bromocriptine & Pergolide
Non-ergot alkaloid derivatives:
Pramipexole & Ropinirole
Have longer duration less fluctuation
Have less tendency to induce dyskinesia
Ineffective in patients not responding to
leveodopa
Can be used in early cases to delay use
of levodopa (in levodopa-naïve patients)
& in advanced cases to augment
levodopa and to decrease fluctuations to
its response
 Pergolide is more potent than Bromocriptine
 Their side effects limit their use and slow rapid
build up of doses (over 2-3 Months)
 Side effects include levodopa side effects in
addition to spasmogenicity & fibrosis (of serous
membranes)
 Pramipexole & Ropinirole
Pramipexole: is cleared by renal
excretion
Ropinirole: is cleared by metabolism
Side effects as levodopa with less
dyskinesia and fluctuation and
No spasmogenicity and
fibrosis
Antiviral (influenza) drug
The mode of action is unknown
• # NMDA glutamate receptors (the primary action)
• # Muscarinic receptors
• Increases release of dopamine
It has little effect on tremors &
Tolerance develops rapidly
 Augment the effect of dopamine
 Weak and play an adjuvant role
 They are the same in efficacy but with some inter-
individual variation in response
Side effects:
 Mood changes
 Xerostomia, blurred vision, constipation, urinary
retention
 Hallucination, confusion
C/I: in glaucoma, SPH, Pyloric stenosis
Parkinson-plus syndromes respond poorly to the standard treatments
for Parkinson disease (PD).
In addition to lack of response to levodopa/carbidopa (Sinemet) or
dopamine agonists in the early stages of the disease, other clinical
clues suggestive of Parkinson-plus syndromes include the following:
 Early onset of dementia
 Early onset of postural instability
 Early onset of hallucinations or psychosis with low doses of
levodopa/carbidopa or dopamine agonists
 Ocular signs, such as impaired vertical gaze, blinking on saccade,
square-wave jerks, nystagmus, blepharospasm, and apraxia of eyelid
opening or closure
 Pyramidal tract signs not explained by previous stroke or spinal cord
lesions
 Autonomic symptoms such as postural hypotension and incontinence
early in the course of the disease
 Prominent motor apraxia
 Alien-limb phenomenon
 Marked symmetry of signs in early stages of the disease
 Truncal symptoms more prominent than appendicular symptoms
 Absence of structural etiology such as a normal-pressure hydrocephalus
(NPH)
 Tremor is rhythmic, involuntary, purposeless
oscillatory movement of body part due to
intermittent muscle contraction
 Types: i. Rest ii. Postural iii. Intention
 Rest Tremor: is maximum at rest & becomes less
prominent with activity eg: parkinson disease,
 Postural Tremor: is maximum while limb posture
is actively maintained against gravity (arm
outstretched) eg: Essential tremor, enhanced
physiologic tremor,
 Intention Tremor: Most prominent during
voluntary movement toward a target eg: cerebellar
disease
 Etiology:
Parkinsonism
Essential tremor
Physiologic tremor
Alcohol
Anxiety
Thyrotoxicosis
Cerebellar disease
Wilson disease
Red nuclear tremor
Drugs (-2agonist, sympathomimetics,
methylxanthine, amphetamine, anticonvulsant,
Poison (Mercury, MPTP)
Essential tremor: Most common involuntary
movement disorder
 High frequency, coarse mainly distal upper
extremity & later become bilateral symmetrical
 Maximum when trying to maintain a posture
 Autosomal dominant pattern of inheritance
 Characteristically improve with alcohol & -
blocker
 Parkinsonism is a slow (4-6 Hz) coarse, rest
tremor typically appears unilaterally, pill rolling
tremor
Physiologic Tremor: In normal individual
8-12Hz, mainly young adults
Cerebellar tremor: intention tremor,
coarse & irregular
Thyrotoxic tremor: fine & rapid but may
be complicated by choreiform involuntary
movement
Red nuclear tremor: the severe, large
amplitude, slow 2-5 Hz, involve both
proximal & distal muscle present at rest
but made worse with action
 Fine rapid, flickering or vermicular twitching
movements due to contraction of a bundle or
fasciculus of muscle fibers
 Fasciculations are much more gross than
fibrillation and can be seen through intact skin
and this continue during sleep
 Exaggerated by fatigue, cold, cholinergic drugs,
caffine
 Characteristic feature of motor neuron disease,
anterior horns cell disease
 Involuntary, spontaneous, localized, transient or
persistent quivering movement that affect a few
muscle bundles with in a single muscle
 Coarse, slower, worm like, usually more
prolonged and involved in wide local area than
fasciculation
 Not affected by motion or position and persist
during sleep
 Most commonly present in orbicularis oculi
 Generalized myokymia (Isaac’s syndrome)
generalized muscle stiffness and persistent
contraction due to underlying continuous
muscle fiber activity
 Slow 2-3Hz rhythmic alternating movement
resemble tremor
 Wide spread involvement, may involved multiple
body parts
 Absent during sleep
 May be intermittent or continuous, synchronous
or asynchronous
 Eg: CNS whipple’ disease

More Related Content

What's hot (20)

Dementia PRESENTATION
Dementia PRESENTATIONDementia PRESENTATION
Dementia PRESENTATION
 
Parkinson's disease
Parkinson's diseaseParkinson's disease
Parkinson's disease
 
Neurosis
NeurosisNeurosis
Neurosis
 
Guillain-Barré syndrome (GBS)
Guillain-Barré syndrome (GBS)Guillain-Barré syndrome (GBS)
Guillain-Barré syndrome (GBS)
 
Movement disorders
Movement disordersMovement disorders
Movement disorders
 
Sleep disorders
Sleep disordersSleep disorders
Sleep disorders
 
Ataxia
AtaxiaAtaxia
Ataxia
 
Motor Neuron Disease
Motor Neuron DiseaseMotor Neuron Disease
Motor Neuron Disease
 
Seizures and epilepsy
Seizures and epilepsySeizures and epilepsy
Seizures and epilepsy
 
Delirium
DeliriumDelirium
Delirium
 
Chorea: Treatment Update
Chorea: Treatment UpdateChorea: Treatment Update
Chorea: Treatment Update
 
Vertigo
VertigoVertigo
Vertigo
 
Encephalitis
EncephalitisEncephalitis
Encephalitis
 
Delirium
DeliriumDelirium
Delirium
 
Dementia
DementiaDementia
Dementia
 
Tremors
TremorsTremors
Tremors
 
TIA
TIATIA
TIA
 
Approach to dystonia
Approach to dystoniaApproach to dystonia
Approach to dystonia
 
Paraplegia
ParaplegiaParaplegia
Paraplegia
 
Dementia
DementiaDementia
Dementia
 

Similar to Extrapyramidal disorders

extrapyramidal system 3-210108074605.pdf
extrapyramidal system 3-210108074605.pdfextrapyramidal system 3-210108074605.pdf
extrapyramidal system 3-210108074605.pdfShinilLenin
 
Extrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemExtrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemChetan Ganteppanavar
 
Extrapyramidal system.pdf very good details
Extrapyramidal system.pdf very good detailsExtrapyramidal system.pdf very good details
Extrapyramidal system.pdf very good detailssudaisahmad16
 
Diseases of nervous system Veterinary Neurology
Diseases of nervous system   Veterinary NeurologyDiseases of nervous system   Veterinary Neurology
Diseases of nervous system Veterinary NeurologyAjith Y
 
Motor Neuron Disease and PT Mx
Motor Neuron Disease and PT MxMotor Neuron Disease and PT Mx
Motor Neuron Disease and PT Mxrichamistry3
 
Involuntary movements
Involuntary movementsInvoluntary movements
Involuntary movementsVitrag Shah
 
PARKINSON DISEASE_032244.pptx
PARKINSON DISEASE_032244.pptxPARKINSON DISEASE_032244.pptx
PARKINSON DISEASE_032244.pptxShubhrimaKhan
 
Hypokinetic Movement Disorders - Parkinson disease
Hypokinetic Movement Disorders - Parkinson diseaseHypokinetic Movement Disorders - Parkinson disease
Hypokinetic Movement Disorders - Parkinson diseaseChetan Ganteppanavar
 
EXTRAPYRAMIDAL DISEASES NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES  NANNIKA PRADHANEXTRAPYRAMIDAL DISEASES  NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES NANNIKA PRADHANNannikaPradhan
 
EXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHANEXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHANthesalberry
 
Movement disorders By Dr Tomser Ali, international school of medicine
Movement disorders By Dr Tomser Ali, international school of medicineMovement disorders By Dr Tomser Ali, international school of medicine
Movement disorders By Dr Tomser Ali, international school of medicineneestom1998
 
Parkinsonism Disease
Parkinsonism DiseaseParkinsonism Disease
Parkinsonism DiseaseVarunsj
 
Autonomic nervous system its examination and lesions.
Autonomic nervous system its examination and lesions.Autonomic nervous system its examination and lesions.
Autonomic nervous system its examination and lesions.Syed hassnasin shah
 
Differential diagnosis of tremors
Differential diagnosis of  tremorsDifferential diagnosis of  tremors
Differential diagnosis of tremorsAhmad Shahir
 
falls and drop attacks in neurology.pptx
falls and drop attacks in neurology.pptxfalls and drop attacks in neurology.pptx
falls and drop attacks in neurology.pptxNehaYadav371751
 

Similar to Extrapyramidal disorders (20)

extrapyramidal system 3-210108074605.pdf
extrapyramidal system 3-210108074605.pdfextrapyramidal system 3-210108074605.pdf
extrapyramidal system 3-210108074605.pdf
 
Extrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal SystemExtrapyramidal System and Disorders of Extrapyramidal System
Extrapyramidal System and Disorders of Extrapyramidal System
 
Extrapyramidal system.pdf very good details
Extrapyramidal system.pdf very good detailsExtrapyramidal system.pdf very good details
Extrapyramidal system.pdf very good details
 
Diseases of nervous system Veterinary Neurology
Diseases of nervous system   Veterinary NeurologyDiseases of nervous system   Veterinary Neurology
Diseases of nervous system Veterinary Neurology
 
Motor Neuron Disease and PT Mx
Motor Neuron Disease and PT MxMotor Neuron Disease and PT Mx
Motor Neuron Disease and PT Mx
 
Involuntary movements
Involuntary movementsInvoluntary movements
Involuntary movements
 
PARKINSON DISEASE_032244.pptx
PARKINSON DISEASE_032244.pptxPARKINSON DISEASE_032244.pptx
PARKINSON DISEASE_032244.pptx
 
Hypokinetic Movement Disorders - Parkinson disease
Hypokinetic Movement Disorders - Parkinson diseaseHypokinetic Movement Disorders - Parkinson disease
Hypokinetic Movement Disorders - Parkinson disease
 
EXTRAPYRAMIDAL DISEASES NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES  NANNIKA PRADHANEXTRAPYRAMIDAL DISEASES  NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES NANNIKA PRADHAN
 
EXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHANEXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHAN
EXTRAPYRAMIDAL DISEASES-DR NANNIKA PRADHAN
 
Basal ganglia disorders.ppt
Basal ganglia disorders.pptBasal ganglia disorders.ppt
Basal ganglia disorders.ppt
 
Localization
LocalizationLocalization
Localization
 
Movement disorders By Dr Tomser Ali, international school of medicine
Movement disorders By Dr Tomser Ali, international school of medicineMovement disorders By Dr Tomser Ali, international school of medicine
Movement disorders By Dr Tomser Ali, international school of medicine
 
Parkinsonism Disease
Parkinsonism DiseaseParkinsonism Disease
Parkinsonism Disease
 
Autonomic nervous system its examination and lesions.
Autonomic nervous system its examination and lesions.Autonomic nervous system its examination and lesions.
Autonomic nervous system its examination and lesions.
 
Tone new
Tone newTone new
Tone new
 
Ataxia
AtaxiaAtaxia
Ataxia
 
Differential diagnosis of tremors
Differential diagnosis of  tremorsDifferential diagnosis of  tremors
Differential diagnosis of tremors
 
Hereditary spastic paraplegia
Hereditary spastic paraplegiaHereditary spastic paraplegia
Hereditary spastic paraplegia
 
falls and drop attacks in neurology.pptx
falls and drop attacks in neurology.pptxfalls and drop attacks in neurology.pptx
falls and drop attacks in neurology.pptx
 

More from rahul arora

diastolic heart failure an enemy in cardiology
diastolic heart failure an enemy in cardiologydiastolic heart failure an enemy in cardiology
diastolic heart failure an enemy in cardiologyrahul arora
 
hemodynamic in cath lab: aortic stenosis and hocm
hemodynamic in cath lab: aortic stenosis and hocmhemodynamic in cath lab: aortic stenosis and hocm
hemodynamic in cath lab: aortic stenosis and hocmrahul arora
 
No reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pciNo reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pcirahul arora
 
Recent advances in management of heart failure
Recent advances in management of heart failureRecent advances in management of heart failure
Recent advances in management of heart failurerahul arora
 
Asd in elderly surgery or leave it alone
Asd in elderly  surgery or leave it aloneAsd in elderly  surgery or leave it alone
Asd in elderly surgery or leave it alonerahul arora
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel diseaserahul arora
 
prosthetic valve replacement
prosthetic valve replacementprosthetic valve replacement
prosthetic valve replacementrahul arora
 
Surgical management of tetralogy of fallot
Surgical management of tetralogy of fallotSurgical management of tetralogy of fallot
Surgical management of tetralogy of fallotrahul arora
 
cirrhotic cardiomyopathy
cirrhotic cardiomyopathycirrhotic cardiomyopathy
cirrhotic cardiomyopathyrahul arora
 

More from rahul arora (9)

diastolic heart failure an enemy in cardiology
diastolic heart failure an enemy in cardiologydiastolic heart failure an enemy in cardiology
diastolic heart failure an enemy in cardiology
 
hemodynamic in cath lab: aortic stenosis and hocm
hemodynamic in cath lab: aortic stenosis and hocmhemodynamic in cath lab: aortic stenosis and hocm
hemodynamic in cath lab: aortic stenosis and hocm
 
No reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pciNo reflow and slow flow phenomenon during pci
No reflow and slow flow phenomenon during pci
 
Recent advances in management of heart failure
Recent advances in management of heart failureRecent advances in management of heart failure
Recent advances in management of heart failure
 
Asd in elderly surgery or leave it alone
Asd in elderly  surgery or leave it aloneAsd in elderly  surgery or leave it alone
Asd in elderly surgery or leave it alone
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel disease
 
prosthetic valve replacement
prosthetic valve replacementprosthetic valve replacement
prosthetic valve replacement
 
Surgical management of tetralogy of fallot
Surgical management of tetralogy of fallotSurgical management of tetralogy of fallot
Surgical management of tetralogy of fallot
 
cirrhotic cardiomyopathy
cirrhotic cardiomyopathycirrhotic cardiomyopathy
cirrhotic cardiomyopathy
 

Recently uploaded

ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 

Recently uploaded (20)

ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 

Extrapyramidal disorders

  • 1. RAHUL ARORA JR 3 , MEDICINE
  • 2.  WHAT IS EXTRAPYRMIDAL SYSTEM?  DEFINITION  ANATOMY  FUNCTIONS  APPROACH TO A CASE OF EXTRAPYRMIDAL DISORDER • CLASSIFICATION OF EXTRAPYRMIDAL DISORDER • DEFINATION • ETIOLOGY • PATHOPHYSIOLOGY • DISTINGUISHING FEATURES  BRIEF DISCUSSION ON • PARKINSONISM • HUNTINGTON’ DISEASE
  • 3.  The term extrapyramidal system, coined by British neurologist Kinnier Wilson, refers to the basal ganglia and an array of brain stem nuclei (red nucleus, reticular formation etc.) to which they are connected.  Components of the extrapyramidal system include the red nuclei, vestibular nuclei, superior colliculus and reticular formation in the brain stem, all of which project via discrete pathways to influence spinal cord motor neurons. Cerebellar projections are also included since they influence not only these brainstem motor pathways, but also the motor cortex itself via the dentatothalamic projection.
  • 4. Basal ganglia Subcortical nuclei Caudate, putamen & globus pallidus : corpus straitum Caudate & putamen : straitum Globus pallidus & putamen : lentiform nuclei Globus pallidus : pallidum
  • 5. Perhaps the most important structures to retain an extrapyramidal definition are the basal ganglia, Sub cortical cell stations for the extra pyramidal motor pathway The neostriatum (caudate and putamen) receives widespread cortical afferents, including those from high order sensory association and motor areas, and projects mainly to the globus pallidus. The latter nucleus is the major outflow for the basal ganglia and, via the ventral anterior thalamus, exerts its major influence on premotor and hence the motor cortices. This pattern of connections suggests that the basal ganglia are involved in complex aspects of motor control, including motor planning and the initiation of movement.
  • 6.
  • 7. pyramidal system extrapyramidal system function Skilful volitional movements Modulate volitional motor movements Finalizes an act Initiate an act connection Direct linkage to spinal cord Multi neuronal and multi synaptic via descending tracts Cortico bulbar and cortical spinal tract reticulo-spinal, rubro-spinal, olivo-spinal and vestibulo-spinal tract. Clinical features spasticity Rigidity( lead pipe/ cog wheel) Reflexes brisk normal Power diminished Usually not affected Planters extensor flexor Involuntary movements absent present
  • 8.  Phylogenetically, corpus striatum is primarily responsible for stereotyped motor activities to maintain tone, posture, locomotion and automatic associated movement.  Regulation of voluntary motor activity  Control of the muscle tone  Maintenance of emotional and associative movements
  • 9. It is now clear that in many extrapyramidal disorders there are specific changes in neurotransmitter profile rather than discrete anatomical lesions 1. Disturbance in the control of voluntary motor activity resulting in involuntary movements which may be of two main types:  Rhythmic and regular as in parkinsonism  Dysrhythmic and irregular as in chorea, athetosis and dystonia 2. Disturbance in the normal muscle tone resulting in hypertonia (rigidity) 3. Disturbance in the maintenance of emotional and associated movements resulting in bradykinesia (mask face, infrequent blinking and loss of swinging during walking)
  • 10. Extrapyramidal disorders are classified broadly on clinical grounds into: 1. The akinetic-rigid syndromes in which poverty of movements predominates 2. The dyskinesisas in which there are a variety of excessive involuntary movements
  • 11. Akinetic-rigid syndromes Idiopathic Parkinson's disease Drug-induced parkinsonism (e.g. phenothiazines) MPTP-induced parkinsonism [methylphenyltetrahydropyridine] Postencephalitic parkinsonism Parkinsonism-plus Childhood akinetic-rigid syndrome Dyskinesias Essential tremor Chorea Hemiballismus Myoclonus Tic or 'habit spasms' Torsion dystonias Paroxysmal dyskinesias
  • 12. Rhythmical Tremor Irregular Slow or sustained (Athetosis / dystonia) Rapid Controllable (Tics) Uncontrollable Distal (Chorea) Proximal (Ballismus) Multifocal (Myoclonus)
  • 13. Only Cogwheel rigidity or rest tremor (Parkinsonism) Cognitive, language, upper motor neuron or sensory sign (Degenerative disease with parkinsonism)
  • 14.  Age- age of disease onset is very important tourette syndrome, typically begins in the first decade, parkinsons disease usually occurs in late age  Past history –About infection (rheumatic fever), jaundice(wilsons disease) • Medical history & Toxin exposure  Drug history- of current, previous & recreational use should be taken details : parkinsonism & dystonia may be produced by dopamine receptor blocking agent  Family history – should be taken and make a pedigree chart if necessary (huntington disease)
  • 15. Associated neuropsychiatric features – Wilson disease, Huntington disease Autonomic symptoms- dizziness, bladder complaints, impotence etc may be prominent & early in MSA, neurodegenerative disease Alcohol responsiveness, essential tremor is characteristically response to alcohol
  • 16.  Specific distribution- • Chorea/ athetosis - mainly in the distal groups • Hemiballismus- mainly proximally • Parkinsons disease- mainly unilateral & asymmetric • Blepherospasm- affect both eye  Specific action & relationship to voluntary movement- • task specific tremor (intention tremor) during pick up a glass of water • Task specific dystonia eg: Writers cramp, musician cramp
  • 17.  Speed of movement-  Rhythm- Continuous – tremor Intermittent – astrexis  Relationship to sleep- Palatal myoclonus, segmental myoclonus, fasciculation & myokymia, persist during sleep , Dystonia diminished on sleep  Supresibility- tics may be voluntary suppressed Slow Intermediate Fast Parkinsonism Chorea Myoclonus Dystonia Tremor Tics Athetosis
  • 18.  Aggravating or precipitating factor- stress and anxiety worsen all movement disorder • Myoclonus may be triggered by specific stimuli- sudden loud noise or touch • Carbohydrate heavy meal, fatigue may precipitate paroxysmal dystonia  Associated sensory symptom- RLS associated with pain or discomfort, tics may be associated with vague discomfort or abnormal sensation  Ameliorating factor- alcohol dramatically improved essential tremor and myoclonic dystonia
  • 19.  2nd commonest neurodegenerative disease of neurons in the nigrostrial dopamine system Clinical Features of Parkinson's Disease Cardinal Features Other Motor Features Nonmotor Features Bradykinesia Rest tremor Rigidity Gait disturbance/postural instability Micrographia Masked facies (hypomimia)equalize Reduced eye blink Soft voice (hypophonia) Dysphagia Freezing Anosmia Sensory disturbances (e.g., pain) Mood disorders (e.g., depression) Sleep disturbances Autonomic disturbances Orthostatic hypotension Gastrointestinal disturbances Genitourinal disturbances Sexual dysfunction Cognitive impairment/Dementia
  • 20. 1- Static tremors  Rhythmic occuring at a rate of 4-8 / second  May start in one hand and spread to other parts of the body  Characteristically pill-rolling movements between the thumb and the forefinger are seen  Tremors increase with emotional, anxiety and fatigue and disappear during sleep and during active voluntary movements
  • 21. 2- Rigidity of the muscles  More proximal than distal  Flexors are affected more than extensor  On clinical examination the resistance may be continuous throughout the act to the same degree (lead pipe rigidity) or interrupted by the tremors (cog wheel rigidity)  Stiffness of the limbs develops causing difficulty in starting movements and walking (slow, shuffling gait)
  • 22. 3- Akinesia: Loss of emotional and associative movements resulting in: Immobile face with infrequent blinking (mask face) Monotonous speech Loss of swinging of the arms during walking
  • 23.  Pathologically, the hallmark features of PD are degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc), reduced striatal dopamine, and intracytoplasmic proteinaceous inclusions known as Lewy bodies.  neuronal degeneration with inclusion body formation can also affect cholinergic neurons of the nucleus basalis of Meynert (NBM), norepinephrine neurons of the locus coeruleus (LC), serotonin neurons in the raphe nuclei of the brainstem, and neurons of the olfactory system, cerebral hemispheres, spinal cord, and peripheral autonomic nervous system.  Indeed, there is evidence that pathology begins in the peripheral autonomic nervous system, olfactory system, and dorsal motor nucleus of the vagus nerve in the lower brainstem, and then spreads in a sequential manner to affect the upper brainstem and cerebral hemispheres. These studies suggest that dopamine neurons are affected in midstage disease.  Several studies suggest that symptoms reflecting nondopaminergic degeneration such as constipation, anosmia, rapid eye movement (REM) behavior sleep disorder, and cardiac denervation precede the onset of the classic motor features of the illness.
  • 24.
  • 25.
  • 26. Differential Diagnosis of Parkinsonism Parkinson's Disease Genetic Sporadic Dementia with Lewy bodies Atypical Parkinsonisms Multiple-system atrophy Cerebellar type (MSA-c) Parkinson type (MSA-p) Progressive supranuclear palsy Corticobasal ganglionic degeneration Frontotemporal dementia Secondary Parkinsonism Drug-induced Tumor Infection Vascular Normal-pressure hydrocephalus Trauma Liver failure Toxins (e.g., carbon monoxide, manganese, MPTP, cyanide, hexane, methanol, carbon disulfide) Other Neurodegenerative Disorders Wilson's disease Huntington's disease Neurodegeneration with brain iron accumulation SCA 3 (spinocerebellar ataxia) Fragile X–associated ataxia-tremor- parkinsonism Prion disease Dystonia-parkinsonism (DYT3) Alzheimer's disease with parkinsonism
  • 27. Modern immunocytochemical techniques and genetic findings suggest that Parkinson-plus syndromes can be broadly grouped into 2 types: synucleinopathies and tauopathies. Clinically, however, 5 separate Parkinson-plus syndromes have been identified, as follows: 1. Multiple system atrophy 2. Progressive supranuclear palsy 3. Parkinsonism-dementia-amyotrophic lateral sclerosis complex 4. Corticobasal ganglionic degeneration 5. Diffuse Lewy body disease Parkinson-plus syndromes respond poorly to the standard treatments for Parkinson disease (PD).
  • 28. In addition to lack of response to levodopa/carbidopa (Sinemet) or dopamine agonists in the early stages of the disease, other clinical clues suggestive of Parkinson-plus syndromes include the following: History and Examination Features Suggesting Diagnoses Other Than Parkinson's Disease Symptoms/Signs Alternative Diagnosis to Consider History Falls as the first symptom PSP Exposure to neuroleptics Drug-induced parkinsonism Onset prior to age 40 If PD, think genetic causes Associated unexplained liver disease Wilson's disease Early hallucinations Lewy body dementia Sudden onset of parkinsonian symptoms Vascular parkinsonism Physical Exam Dementia as first symptom Dementia with Lewy bodies Prominent orthostasis MSA-p Early dysarthria MSA-c Lack of tremor Various Parkinson's-plus syndromes High frequency (8–10 Hz) symmetric tremor Essential tremor
  • 29. Diagnosis of PD  clinical examination  No disease-specific biological marker available  Positron Emission Tomography (PET) or Single-photon Emission Computed Tomography (SPECT) with dopaminergic radioligands  Exclusion of several causes of secondary Parkinsonism
  • 30. (A)  Dopamine  Carbidopa/l-dopa  Dopamine agonists: Apomorphine(off phenomenon),  s/c, i.v. Cabergoline Ropinirole, Pramipexole  COMT inhibitors: Entacapone  MAO Inhibitors: e.g. Selegiline (B-type)  Inhibitors of dopamine re-uptake: Amantadine (2)  Acetylcholine  Anticholinergic  Antihistaminics
  • 31. Drugs commonly used in the treatment of Parkinson disease MEDICATION STARTING DOSE TARGET DOSE MAIN BENEFIT SIDE EFFECTS Carbidopa-L-dopa (Sinemet) 25/100 tid empty stomach Up to 50/250 q 3 h Reduction of tremor and bradykinesia; less effect on postural difficulties Nausea, dyskinesias, orthostatic hypotension, hallucinations, confusion, arrhythmia Controlled release carbidopa-L-dopa 25/100 tid Up to 50/200 q 4 h Dopamine agonists Ropinirole(D3) 0.125 mg tid 0.5 to 1.5 mg/day Moderate effects on all aspects; reduced motor fluctuations of L-dopa, neuroprotective, neurotrophic Orthostatic hypotension, excessive and abrupt sleepiness, confusion, hallucinations, impulse control disorders Pramipexole(D2) 0.25 mg tid 8 to 24 mg/day Glutamate agonist Amantadine (Symmetrel) 100 mg/day 100 mg bid-tidSmoothing of motor fluctuations Leg swelling, congestive heart failure, prostatic outlet obstruction, confusion, hallucinations, insomnia Anticholinergics Benztropine (Cogentin) 0.5 mg per day Up to 4 mg per day Tremor reduction, less effect on other features, drug induced parkinsonism Atropinic effects: dry mouth, urinary outlet obstruction, confusion and psychosisTrihexyphenidyl (Artane) 0.5 mg bid Up to 2 mg tid MAO-B inhibitor selegiline, 5mg/day bd Neuroprotection, adjuntive therapy Insomnia Rasagiline 1mg/day COMT inhibitors Entacapone 200 mg with L-dopa Urine discoloration, diarrhea, increased dyskinesias
  • 32.  Stereotactic neurosurgery: pallidotomy, thalamotomy ,sub thalamotomy Indications 1.idiopathic parkinsons 2.levodopa unhelpful 3.intractable PD 4.drug dyskinesias  Deep brain stimulation: dyskinesia  Tissue transplantation: Experimental transplantation of fetal or autologous dopamine-containing adrenal medulla or stem cell research has produced no promising results in PD to date.  Physiotherapy and physical aids  Neuropsychiatric aspects: Cognitive impairment and depression are common as PD progresses. SSRIs are the drugs of choice for depression.
  • 33.  Sudden, brief, rapid, jerky, purposeless, non- repetitive, involuntary movement  Most characteristically in distal parts of upper extremity but may also involved proximal part, lower extremity, trunk, face & tongue PATHOLOGY  Damage to caudate nucleus
  • 34.  Disease characterized by chorea:  Inherited disorder: Huntington disease, wilson disease, benign hereditry chorea, neuroacanthocytosis  Infectious causes: Rheumatic chorea (sydenham chorea), HIV disease  Structural lesion of the basal ganglia- infarct, neoplasm, trauma  Chorea of systemic disease: SLE, thyrotoxicosis, polycythemia vera, hyperosmolar non-ketotic hyperglycemia  Pregnancy (chorea gravidarum)  Drugs: Neuroleptics, OCP, excessive dose of levodopa or dopamine agonist, phenytoin cocaine
  • 35.  Hypotonia  Pronator sign  Milkmaid’s grip  Spooning sign  Pendular knee jerk “hung up reflex”  Lizard tongue Increased by excitement, diminished by sleep Sydenham chorea (Saint vitus dance) more common in female and childhood (5-15yrs), associated with prior exposer to group a streptococcal infection, late manifestation Huntington's disease progressive fatal autosomal dominant disorder characterized by motor, behavioral & cognitive dysfunction, in early stages chorea is focal or segmental but it progress over time to involve multiple body region
  • 36. Etiology  HD is caused by an increase in the number of polyglutamine (CAG) repeats (>40) in the coding sequence of the huntingtin gene located on the short arm of chromosome 4. The larger the number of repeats, the earlier the disease is manifest. Treatment  multidisciplinary approach  Dopamine-blocking agents may control the chorea. Tetrabenazine  depression and anxiety can be greater problems, and patients should be treated with appropriate antidepressant and antianxiety drugs and monitored for mania and suicidal ideations.  Psychosis can be treated with atypical neuroleptics such as clozapine, quetiapine, and risperidone  There is no adequate treatment for the cognitive or motor decline
  • 37.  Slow, distal, purposeless, writhing involuntary movement  They are more sustained and larger in amplitude than those in chorea  The mainly involved the extremities (distal portion, fingers & hands) face, neck & trunk  Movement are characterized by any combination flexion, extension, abduction, pronation, & supination often alternating and in varying degree  Predominant pathologic changes are in the putamen
  • 38. Causes: cerebral palsy, perinatal injury to basal ganglia, wilson disease Choreoathetosis: the movement live between chorea & athetosis in rate and rhythmicity eg: cerebral palsy ( Neonatal jaundice) Pseudoathetosis: (sensory athetosis) undulating & writhing movement of extremities due to loss of position sense as a result of parietal lobe lesion, tabes dorsalis, peripheral nerve disease
  • 39. A wild, flinging, large amplitude movements on one side of the body Proximal upper limb muscles predominantly affected Ballastic movement of hemiballismus resemble that of chorea but are more pronounced, rapid & forceful Movement ceaseless during the walking state and disappear only with the deep sleep
  • 40.  Usually self limiting and tends to resolve spontaneously after weeks to months  Due to infarction or hemorrhage in the regions of contralateral subthalamic nucleus, results in disinhibition of the motor thalamus and cortex resulting in contralateral hyperkinetic movement.  Treatment:  Dopa blocking agent  Pallidotomy can be done.
  • 41.  Sustained or repetitive involuntary muscle contraction leading to twisting movements and abnormal posture  Can involve individual muscle or multiple muscle groups.  Often affect the extremities neck, trunk, eyelids, face & vocal cords  Dystonic movements are patterned tending to recur in same location  When duration is very brief less than one second- dystonic spasm, when for several seconds, dystonic movement & when prolonged minutes to hours- dystonic posture Pathophysiology of Dystonia  not known.  co-contracting synchronous bursts of agonist and antagonist muscle groups due to loss of inhibition at multiple levels of the nervous system as well as increased cortical excitability and reorganization.  Attention has focused on the basal ganglia as the site of origin of at least some types of dystonia as there are alterations in blood flow and metabolism in basal ganglia structures. Further, ablation or stimulation of the globus pallidus can both induce and ameliorate dystonia.
  • 42.  Dystonia can be generalized or focal: primary or secondary  Generalized dystonia is mainly primary dystonia involving larger portion of body often producing distorted posture of limbs & trunk (Torsion dystonia)  Idiopathic torsion dystonia (dystonia musculorm deformance) is predominantly childhood onset form of dystonia with autosomal dominant pattern of inheritance  May starts distally usually in the foot in the planter flexation & inversion & speed to opposite side, upper extremity trunk & face  There is peculiar axial involvement of spine (twisting)
  • 43.  Dopa responsive dystonia ( Segawa variant) dominantly inherited form of dystonia in early childhood 1-12yrs typically present with foot dystonia resulting in gait disturbance and there is excellent response to small doses of levodopa.  Diurnal variation, worsen with day progresses Focal dystonia is a most common, 4th to 6th decade and more common in female: • Blephero spasm • Oromandibular dystonia • Spasmodic dysphonia • Cervical dystonia • Limb dystonia (writer’s cramp)
  • 44. Secondary dystonia: Due to drugs: Neuroleptics, (Phenothiazine, Butyrophenone), chronic levodopa treatment in parkinsons disease  Discrete lesion in the stratum, palladum, thalamus, cortex & brain stem Dystonia plus syndrome: May occur in the neurodegenerative condition (Huntington disease, Wilson disease, parkinson disease, corticobasal degeneration & progressive supranuclear palsy)
  • 45. symptomatic  Levodopa should be tried in all cases of childhood-onset dystonia to rule out DRD.  High-dose anticholinergics (e.g., trihexyphenidyl 20–120 mg/d) may be beneficial in children, but adults can rarely tolerate high doses because of cognitive impairment with hallucinations.  Oral baclofen (20–120 mg), Tetrabenazine (the usual starting dose is 12.5 mg/d and the average treating dose is 25–75 mg/d) may be helpful in some patients, but use may be limited by sedation and the development of parkinsonism.  Botulinum toxin has become the preferred treatment for patients with focal dystonia, particularly where involvement is limited to small muscle groups such as in blepharospasm, torticollis, and spasmodic dysphonia.  Surgical therapy is an alternative for patients with severe dystonia who are not responsive to other treatments. Peripheral procedures such as rhizotomy and myotomy were used in the past to treat cervical dystonia, but are now rarely employed. DBS of the pallidum can provide dramatic benefits for patients with primary DYT1 dystonia  Supportive treatments such as physical therapy and education are important and should be a part of the treatment regimen.
  • 46.  Sudden, brief (<100ms) shock like, jerky involuntary movement consisting of single or repetitive muscle discharges  Myoclonus is seen principally in the muscles of extremities and trunk but the involvement is often multifocal, diffuse or wide spread  Can often spontaneously, association with voluntary movement (action myoclonus) or in response to external stimulus (reflex or startle myoclonus)  Myoclonic jerks defer from tics in that they interfere with normal movement and not suppressible
  • 47. Symptomatic causes of myoclonus:  Metabolic endogenous- Hypoxia, uraemia, hepatic failure, hypoglycemia, hyponatraemia, non-ketotic hyperglycemia  Degenerative: Alzheimer’s disease, Huntington disease, multisystem atrophy, corticobasal degeneration  Infectious: Creutzfeldt –Jakob disease, EBV etc  Autoimmune: Multiple sclerosis  Neoplastic: Neuroblastoma, paraneoplastic disorders (ovarian, lung & breast)  Frequently associated with epilepsy, electric shock, heat stroke  Drugs: Amantadine, lithium, metoclopramide, levodopa & dopamine agonist, cocaine, strychnine
  • 48.  Opsoclonus- Myoclonus (Kinsbourne syndrome)- Dancing eye & dancing feet  Due to the post infectious encephalopathy or as a paraneoplastic syndrome due to neuroblastoma  Palatal myoclonus- involuntary rhythmic movement of soft palate and pharynx the movements are generally not influenced by drugs or sleep palatal myoclonus occur with lesions involving the connections between the inferior olivary, dentate & red nuclei  Astrexis: particularly in hepatic encephalopathy, negative myoclonus inability to sustained normal muscle tone presenting with slow & irregular flapping motion
  • 49.  Acute- Dystonia is most common acute drug reaction can develop within minutes of exposure typically generalized in children and focal in adults  Treatment: parenteral administration of anticholinergics (benztropine or diphenhydramine) or benzodiazepines (lorazepam or diazepam).  Subacute- Akathisia is commonest reaction it consist of motor restlessness within in need to move and that to elevated by movement.  Treatment: Removing the offending agent.If not possible, give benzodiazepines, anticholinergics, blockers, or dopamine agonists for symptomatic improvement.
  • 50. Chronic- Tardive syndrome after months to years after initiation of treatment A typically comprises choreiform movement involving the mouth lip, tongue, and in severe cases trunk, limbs and respiratory muscles can be affected Is more common in elderly women & with underlying organic cerebral dysfunction (Schrizophrenia)
  • 51.
  • 52.  Brief, repeated, sterotyped muscle contraction that often suppressible  Quick, irregular, seemingly purposeful act but relatively involuntary  Patient have some degree of awareness of movement and in response to urge of some compelling inner forces  Exaggerated by emotional strain and tension and stop during sleep  May involved any portion of body
  • 53.  Eg: Repetitive blinking, facial contortions, shoulder shrugging, also involved vocal tract producing throat clearing  Gilles de la Tourette Syndrome characterized by multiple motor tics and vocalizations  Motor tics can be simple/ complex & vocal tics can be simple (grunting) or complex (echolalia)  Tourette syndrome is a disease of early childhood in the first decade and mainly in Boys an associated with some regressive behaviour
  • 54.  Contrary to dopamine, it can pass into the brain where it is decarboxylated into dopamine  Levodopa is combined with a peripheral L-AA decarboxylase inhibitor e.g. carbidopa or benserazid to   delivery of l-dopa into the brain   peripheral adverse effects of dopamine   Carbidopa if peripheral adverse effects are prominent  It has dramatic initial response, decreases with time (wear off) due to the progressive loss of neurons
  • 55.
  • 56. Combined with carbidopa is the most potent oral therapy for Parkinson’s disease Symptoms of Parkinson’s disease but does not stop the progression (deterioration) of the disease i.e. Symptomatic treatment From the third year its efficacy declines
  • 57.  Peripheral: • GIT: Nausea & Vomiting • CVS: Orthostatic hypotension, Dysrhythmias • Blood dyscrasias & Positive reaction to Coombs test • Mydriasis and Brownish discoloration of urine & saliva  CNS Effects: • Visual & Auditory hallucinations & vivid dreams • Dyskinesias: opposite of Parkinsonian symptoms • Mood changes, depression & Anxiety  Long-term levodopa Complications: • Wearing off (fluctuations), Dyskinesias
  • 58. Ergot alkaloid derivatives: Bromocriptine & Pergolide Non-ergot alkaloid derivatives: Pramipexole & Ropinirole
  • 59. Have longer duration less fluctuation Have less tendency to induce dyskinesia Ineffective in patients not responding to leveodopa Can be used in early cases to delay use of levodopa (in levodopa-naïve patients) & in advanced cases to augment levodopa and to decrease fluctuations to its response
  • 60.  Pergolide is more potent than Bromocriptine  Their side effects limit their use and slow rapid build up of doses (over 2-3 Months)  Side effects include levodopa side effects in addition to spasmogenicity & fibrosis (of serous membranes)
  • 61.  Pramipexole & Ropinirole Pramipexole: is cleared by renal excretion Ropinirole: is cleared by metabolism Side effects as levodopa with less dyskinesia and fluctuation and No spasmogenicity and fibrosis
  • 62. Antiviral (influenza) drug The mode of action is unknown • # NMDA glutamate receptors (the primary action) • # Muscarinic receptors • Increases release of dopamine It has little effect on tremors & Tolerance develops rapidly
  • 63.  Augment the effect of dopamine  Weak and play an adjuvant role  They are the same in efficacy but with some inter- individual variation in response Side effects:  Mood changes  Xerostomia, blurred vision, constipation, urinary retention  Hallucination, confusion C/I: in glaucoma, SPH, Pyloric stenosis
  • 64. Parkinson-plus syndromes respond poorly to the standard treatments for Parkinson disease (PD). In addition to lack of response to levodopa/carbidopa (Sinemet) or dopamine agonists in the early stages of the disease, other clinical clues suggestive of Parkinson-plus syndromes include the following:  Early onset of dementia  Early onset of postural instability  Early onset of hallucinations or psychosis with low doses of levodopa/carbidopa or dopamine agonists  Ocular signs, such as impaired vertical gaze, blinking on saccade, square-wave jerks, nystagmus, blepharospasm, and apraxia of eyelid opening or closure  Pyramidal tract signs not explained by previous stroke or spinal cord lesions  Autonomic symptoms such as postural hypotension and incontinence early in the course of the disease  Prominent motor apraxia  Alien-limb phenomenon  Marked symmetry of signs in early stages of the disease  Truncal symptoms more prominent than appendicular symptoms  Absence of structural etiology such as a normal-pressure hydrocephalus (NPH)
  • 65.
  • 66.  Tremor is rhythmic, involuntary, purposeless oscillatory movement of body part due to intermittent muscle contraction  Types: i. Rest ii. Postural iii. Intention  Rest Tremor: is maximum at rest & becomes less prominent with activity eg: parkinson disease,  Postural Tremor: is maximum while limb posture is actively maintained against gravity (arm outstretched) eg: Essential tremor, enhanced physiologic tremor,  Intention Tremor: Most prominent during voluntary movement toward a target eg: cerebellar disease
  • 67.  Etiology: Parkinsonism Essential tremor Physiologic tremor Alcohol Anxiety Thyrotoxicosis Cerebellar disease Wilson disease Red nuclear tremor Drugs (-2agonist, sympathomimetics, methylxanthine, amphetamine, anticonvulsant, Poison (Mercury, MPTP)
  • 68. Essential tremor: Most common involuntary movement disorder  High frequency, coarse mainly distal upper extremity & later become bilateral symmetrical  Maximum when trying to maintain a posture  Autosomal dominant pattern of inheritance  Characteristically improve with alcohol & - blocker  Parkinsonism is a slow (4-6 Hz) coarse, rest tremor typically appears unilaterally, pill rolling tremor
  • 69. Physiologic Tremor: In normal individual 8-12Hz, mainly young adults Cerebellar tremor: intention tremor, coarse & irregular Thyrotoxic tremor: fine & rapid but may be complicated by choreiform involuntary movement Red nuclear tremor: the severe, large amplitude, slow 2-5 Hz, involve both proximal & distal muscle present at rest but made worse with action
  • 70.  Fine rapid, flickering or vermicular twitching movements due to contraction of a bundle or fasciculus of muscle fibers  Fasciculations are much more gross than fibrillation and can be seen through intact skin and this continue during sleep  Exaggerated by fatigue, cold, cholinergic drugs, caffine  Characteristic feature of motor neuron disease, anterior horns cell disease
  • 71.  Involuntary, spontaneous, localized, transient or persistent quivering movement that affect a few muscle bundles with in a single muscle  Coarse, slower, worm like, usually more prolonged and involved in wide local area than fasciculation  Not affected by motion or position and persist during sleep  Most commonly present in orbicularis oculi  Generalized myokymia (Isaac’s syndrome) generalized muscle stiffness and persistent contraction due to underlying continuous muscle fiber activity
  • 72.  Slow 2-3Hz rhythmic alternating movement resemble tremor  Wide spread involvement, may involved multiple body parts  Absent during sleep  May be intermittent or continuous, synchronous or asynchronous  Eg: CNS whipple’ disease